Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 36.80M P/E - EPS this Y 56.60% Ern Qtrly Grth -
Income -64.83M Forward P/E -1.29 EPS next Y 10.50% 50D Avg Chg 11.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -49.00%
Dividend N/A Price/Book 0.97 EPS next 5Y - 52W High Chg -86.00%
Recommedations 2.60 Quick Ratio 7.10 Shares Outstanding 33.15M 52W Low Chg 86.00%
Insider Own 10.43% ROA -49.62% Shares Float 15.20M Beta 0.10
Inst Own 57.90% ROE -104.04% Shares Shorted/Prior 130.12K/149.87K Price 1.10
Gross Margin - Profit Margin - Avg. Volume 1,161,178 Target Price 2.00
Oper. Margin - Earnings Date Aug 7 Volume 1,826,389 Change 0.00%
About Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops novel therapeutic products for the acute treatment of migraines. The company's product candidature includes STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. As of June 8, 2023, Satsuma Pharmaceuticals, Inc. operates as a subsidiary of Shin Nippon Biomedical Laboratories, Ltd.

STSA Chatroom

User Image NVDAMillionaire Posted - 3 months ago

$STSA Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA): Navigating the Challenges of Developing a Novel Migraine Treatment http://beyondspx.com/2024/08/05/satsuma-pharmaceuticals-inc-nasdaqstsa-navigating-the-challenges-of-developing-a-novel-migraine-treatment/

User Image HIT4THECYCLE Posted - 11 months ago

$STSA my STSA shares turned into this identifier “804CVR017” in my account. Will this ever become active? Trying to dig up info on it.

User Image MrEggo Posted - 11 months ago

@NFerr37 $STSA after you lost your ass at $ktov

User Image TrendyChart Posted - 1 year ago

Upcoming Earnings Report: $STSA Satsuma Pharma will be reporting on 11/17/2023 at 4:00PM | Do you anticipate good or bad earnings for this stock?

User Image TrendyChart Posted - 1 year ago

Upcoming Earnings Report: $STSA Satsuma Pharma will be reporting on 11/17/2023 at 4:00PM | Are you optimistic or pessimistic about earnings on this stock? See more at SweepCast.com

User Image TrendyChart Posted - 10/31/23

Upcoming Earnings Report: $STSA Satsuma Pharma will be reporting on 11/10/2023 at 4:00PM | Will earnings beat estimates or miss the mark?

User Image TrendyChart Posted - 10/26/23

Upcoming Earnings Report: $STSA Satsuma Pharma will be reporting on 11/06/2023 at 4:00PM | Are you leaning towards a positive or negative earnings stance?

User Image fin_researcher Posted - 1 year ago

Don't lose hope if you're impacted by the $STSA stock drop, there could be a chance to regain your losses: https://11thestate.com/cases/stsa-mna-case

User Image TrendyChart Posted - 1 year ago

Upcoming Earnings Report: $STSA Satsuma Pharma will be reporting on 10/13/2023 at 4:00PM | Are you optimistic or pessimistic about earnings on this stock?

User Image SmallCapManager Posted - 09/28/23

@Joefallin @Alexii Pretty sure I was correct on $CABA, $SGTX, $STSA and others but keep nitpicking ones that haven’t materialized yet my number 1 fan! It also gives me pleasure to stay in your head rent free. Cheers 🍻

User Image BecomJapan Posted - 09/27/23

@madan_shatri @Jmoney914 Sure....but has there ever been a pipeline as de-risked as this one? They have all the data and know what to avoid from the failed trial of MAP0004 with the Allergan subsidiary and also the STS101 failure by $STSA (https://seekingalpha.com/article/4376440-satsuma-not-all-over-for-migraine-treatment-despite-trial-failure ) and seem to be able to see that iSperse can overcome the problems that they faced.........Lets see!

User Image Mattedbumhair Posted - 1 year ago

$STSA So what's the new ticker?

User Image deckienaldo Posted - 1 year ago

$STSA what happened here,not on Nasdaq anymore?

User Image stockilluminati Posted - 1 year ago

$STSA https://www.stockilluminati.com/stsa/news.php - Leaven Partners Second Quarter 2023 Letter To Partners

User Image cctranscripts Posted - 1 year ago

Securities registration termination [Section 12(g)] https://www.conferencecalltranscripts.org/summary/?id=12296965 $STSA

User Image Quantisnow Posted - 1 year ago

$STSA 📜 SEC Form 15-12G filed by Satsuma Pharmaceuticals Inc. https://quantisnow.com/i/4660775?utm_source=stocktwits 45 seconds delayed.

User Image risenhoover Posted - 1 year ago

$STSA / Satsuma Pharmaceuticals files form 15-12G https://fintel.io/sf/us/stsa?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image theflynews Posted - 1 year ago

Biotech Alert: Searches spiking for these stocks today - $STSA - https://thefly.com/permalinks/entry.php/STSAid3731689

User Image STCKPRO Posted - 1 year ago

$STSA NEW ARTICLE : Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society's 65th Annual Scientific Meeting https://www.stck.pro/news/STSA/53141571/

User Image Quantisnow Posted - 1 year ago

$STSA 📰 Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society's 65th Annual Scientific Meeting https://quantisnow.com/i/4644691?utm_source=stocktwits 45 seconds delayed.

User Image Stock_Titan Posted - 1 year ago

$STSA Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific Meeting https://www.stocktitan.net/news/STSA/satsuma-pharmaceuticals-and-snbl-announce-three-abstracts-on-sts101-v0vba6o310t4.html

User Image cctranscripts Posted - 1 year ago

Braden M Leonard just issued a filing suggesting it has sold all of its Sterling Financial Corp https://www.conferencecalltranscripts.org/summary/?id=12278661 $STSA

User Image cctranscripts Posted - 1 year ago

Sterling Financial Corporation insider just disposed of 5,914,252 shares https://www.conferencecalltranscripts.org/summary/?id=12276567 $STSA

User Image Quantisnow Posted - 1 year ago

$STSA 📜 SEC Form 4 filed by Ra Capital Management, L.P. https://quantisnow.com/i/4632427?utm_source=stocktwits Get the next market-moving insight 45 seconds early at ➡️ https://quantisnow.com/feed ⬅️

User Image cctranscripts Posted - 1 year ago

RA Capital Healthcare Fund, L.P. just issued a filing suggesting it has sold all of its Sterlin https://www.conferencecalltranscripts.org/summary/?id=12275387 $STSA

User Image Quantisnow Posted - 1 year ago

$STSA 📜 SEC Form SC 13D/A filed by Satsuma Pharmaceuticals Inc. (Amendment) https://quantisnow.com/i/4631643?utm_source=stocktwits 45 seconds delayed.

User Image shortablestocks Posted - 1 year ago

Zero shares available to short currently in $STSA. https://shortablestocks.com/?STSA

Analyst Ratings
HC Wainwright & Co. Neutral Apr 18, 23
Mizuho Neutral Mar 30, 23
HC Wainwright & Co. Buy Mar 30, 23
Mizuho Neutral Nov 15, 22
HC Wainwright & Co. Buy Nov 15, 22
SVB Leerink Market Perform Nov 15, 22
SVB Leerink Outperform Oct 10, 22
HC Wainwright & Co. Buy Sep 21, 22
Ladenburg Thalmann Buy Aug 31, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Leonard Braden Michael 10% Owner 10% Owner Nov 21 Buy 0.7116 150,000 106,740 150,000 11/23/22